Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124976523 | 12497652 | 3 | F | 2014 | 20160817 | 20160625 | 20160819 | PER | US-TAKEDA-2016MPI005835 | TAKEDA | 0.00 | F | Y | 0.00000 | 20160819 | MD | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 124976523 | 12497652 | 1 | PS | VELCADE | BORTEZOMIB | 1 | Unknown | UNK, 1/WEEK | 21602 | INJECTION | /wk | ||||||||
| 124976523 | 12497652 | 2 | SS | VELCADE | BORTEZOMIB | 1 | Unknown | UNK | 21602 | INJECTION | |||||||||
| 124976523 | 12497652 | 3 | SS | VELCADE | BORTEZOMIB | 1 | Unknown | UNK | 21602 | INJECTION | |||||||||
| 124976523 | 12497652 | 4 | SS | VELCADE | BORTEZOMIB | 1 | Unknown | UNK UNK, Q2WEEKS | 21602 | INJECTION | QOW | ||||||||
| 124976523 | 12497652 | 5 | SS | VELCADE | BORTEZOMIB | 1 | Unknown | UNK UNK, Q2WEEKS | 21602 | INJECTION | QOW | ||||||||
| 124976523 | 12497652 | 6 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | UNK | U | 0 | |||||||||
| 124976523 | 12497652 | 7 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | UNK | U | 0 | |||||||||
| 124976523 | 12497652 | 8 | SS | DEXAMETHASONE. | DEXAMETHASONE | 1 | Unknown | UNK | U | 0 | |||||||||
| 124976523 | 12497652 | 9 | SS | REVLIMID | LENALIDOMIDE | 1 | Unknown | UNK | U | 0 | |||||||||
| 124976523 | 12497652 | 10 | SS | REVLIMID | LENALIDOMIDE | 1 | Unknown | UNK | U | 0 | |||||||||
| 124976523 | 12497652 | 11 | SS | CYCLOPHOSPHAMIDE. | CYCLOPHOSPHAMIDE | 1 | Unknown | UNK | U | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 124976523 | 12497652 | 1 | Plasma cell myeloma |
| 124976523 | 12497652 | 6 | Plasma cell myeloma |
| 124976523 | 12497652 | 9 | Plasma cell myeloma |
| 124976523 | 12497652 | 11 | Plasma cell myeloma |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 124976523 | 12497652 | Diarrhoea | |
| 124976523 | 12497652 | Drug effect decreased | |
| 124976523 | 12497652 | Fatigue | |
| 124976523 | 12497652 | Musculoskeletal chest pain | |
| 124976523 | 12497652 | Neuropathy peripheral |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 124976523 | 12497652 | 2 | 20141006 | 0 | ||
| 124976523 | 12497652 | 3 | 20141103 | 0 | ||
| 124976523 | 12497652 | 5 | 20140620 | 0 | ||
| 124976523 | 12497652 | 6 | 20140620 | 0 | ||
| 124976523 | 12497652 | 7 | 20141006 | 0 | ||
| 124976523 | 12497652 | 8 | 20141103 | 0 | ||
| 124976523 | 12497652 | 9 | 20140620 | 0 | ||
| 124976523 | 12497652 | 10 | 20141103 | 0 | ||
| 124976523 | 12497652 | 11 | 20141006 | 0 |